RetinalGenix Technologies (RTGN) Operating Expenses (2020 - 2026)

RetinalGenix Technologies has disclosed Operating Expenses across 7 years of filings, most recently posting $589229.0 for Q1 2026.

• Operating Expenses for Q1 2026 came in at $589229.0, changed 0.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.4 million (down 12.0% YoY), and the FY2025 annual result was $2.4 million, down 43.84% from the prior year.
• Operating Expenses came in at $589229.0 for Q1 2026 at RetinalGenix Technologies, down from $622059.0 in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $2.5 million in Q3 2022 to a low of $351183.0 in Q2 2023.
• The 5-year median for Operating Expenses is $622059.0 (2025), against an average of $783923.8.
• Across the five-year window, Operating Expenses soared 355.26% in 2022 and plunged 72.66% in 2025, its largest moves.
• RetinalGenix Technologies' Operating Expenses stood at $674006.0 in 2022, then retreated by 19.78% to $540676.0 in 2023, then surged by 60.18% to $866067.0 in 2024, then fell by 28.17% to $622059.0 in 2025, then slipped by 5.28% to $589229.0 in 2026.
• The last three Operating Expenses figures came in at $589229.0 (Q1 2026), $622059.0 (Q4 2025), and $567833.0 (Q3 2025), per Business Quant data.